Literature DB >> 28993832

[Diagnostics and treatment of primary hyperparathyroidism].

C Nies1.   

Abstract

Primary hyperparathyroidism is a disease that occurs more frequently than generally thought and is often overlooked. Classical symptoms are bone pain and osteoporosis, renal calculi and peptic ulcers. Many patients are asymptomatic or have unspecific complaints. It is easy to establish the biochemical diagnosis based on calcium and parathormone (PTH) levels and 24-h urine calcium excretion. The most sensitive localization procedures for parathyroid adenomas are sonography and Tc-99m-MIBI scintigraphy. The indication for surgery is undisputed in symptomatic patients; however, there is controversy concerning patients without classical symptoms. Operative therapy is highly successful. Focused operative procedures are currently available besides the traditional 4‑gland exploration. When focused techniques are used, the operative success should be confirmed by intraoperative determination of the parathormone level.

Entities:  

Keywords:  Localization procedures; Parathormone; Parathyroidectomy; Quick PTH assay; Surgical indication

Mesh:

Substances:

Year:  2017        PMID: 28993832     DOI: 10.1007/s00104-017-0517-x

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  26 in total

1.  Development of a formula to predict parathyroid carcinoma in patients with primary hyperparathyroidism.

Authors:  Elias Karakas; Hans-Helge Müller; Vladimir K Lyadov; Stephanie Luz; Ralph Schneider; Matthias Rothmund; Detlef K Bartsch; Katja Schlosser
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

2.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

3.  Minimally invasive, video-assisted parathyroid surgery for primary hyperparathyroidism.

Authors:  P Miccoli; A Pinchera; G Cecchini; M Conte; C Bendinelli; E Vignali; A Picone; C Marcocci
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

4.  The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.

Authors:  Scott M Wilhelm; Tracy S Wang; Daniel T Ruan; James A Lee; Sylvia L Asa; Quan-Yang Duh; Gerard M Doherty; Miguel F Herrera; Janice L Pasieka; Nancy D Perrier; Shonni J Silverberg; Carmen C Solórzano; Cord Sturgeon; Mitchell E Tublin; Robert Udelsman; Sally E Carty
Journal:  JAMA Surg       Date:  2016-10-01       Impact factor: 14.766

5.  How asymptomatic is asymptomatic primary hyperparathyroidism?

Authors:  C Hasse; H Sitter; S Bachmann; A Zielke; M Koller; C Nies; W Lorenz; M Rothmund
Journal:  Exp Clin Endocrinol Diabetes       Date:  2000       Impact factor: 2.949

6.  Conventional bilateral cervical exploration versus open minimally invasive parathyroidectomy under local anaesthesia for primary hyperparathyroidism.

Authors:  A Bergenfelz; V Kanngiesser; A Zielke; C Nies; M Rothmund
Journal:  Br J Surg       Date:  2005-02       Impact factor: 6.939

7.  Impact of parathyroidectomy for primary hyperparathyroidism on quality of life: A case-control study using Short Form Health Survey 36.

Authors:  Roderick Dulfer; Wanda Geilvoet; Annelien Morks; Esther M M van Lieshout; Casper P C Smit; Els J M Nieveen van Dijkum; Klaas In't Hof; Frits van Dam; Casper H J van Eijck; Peter W de Graaf; Tessa M van Ginhoven
Journal:  Head Neck       Date:  2016-05-20       Impact factor: 3.147

8.  Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy.

Authors:  Damita L Thomas; Twyla Bartel; Yusuf Menda; James Howe; Michael M Graham; Malik E Juweid
Journal:  Clin Nucl Med       Date:  2009-10       Impact factor: 7.794

9.  Primary hyperparathyroidism in patients who have received radiation therapy and in patients who have not received radiation therapy.

Authors:  S Tezelman; J M Rodriguez; W Shen; A E Siperstein; Q Y Duh; O H Clark
Journal:  J Am Coll Surg       Date:  1995-01       Impact factor: 6.113

Review 10.  Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review.

Authors:  Julius Simoni Leere; Jesper Karmisholt; Maciej Robaczyk; Peter Vestergaard
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-20       Impact factor: 5.555

View more
  1 in total

Review 1.  Surgical options in treating patients with primary hyperparathyroidism.

Authors:  Masa Majcen; Marko Hocevar
Journal:  Radiol Oncol       Date:  2020-02-29       Impact factor: 2.991

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.